Anabolic steroids and frailty

Journal of the American Medical Directors Association

Volumn 11, Issue 8, 2010, Pages 533-536

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; NANDROLONE; OSTARINE; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TESTOSTERONE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

AGING; ANEMIA; ANOREXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; DRUG ERUPTION; EDITORIAL; EXERCISE; HEART FAILURE; HEART INFARCTION; HUMAN; LONG TERM CARE; MALNUTRITION; UNSPECIFIED SIDE EFFECT; VITAMIN D DEFICIENCY;

EID: 77957240880     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.07.008     Document Type: Editorial

References (104)

1. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
2. Abellan van Kan G., Rolland Y.M., Morley J.E., Vellas B. Frailty: Toward a clinical definition. J Am Med Dir Assoc 2008, 9:71-72.
3. Morley J.E., Haren M.T., Rolland Y., Kim M.J. Frailty. Med Clin North Am 2006, 90:837-847.
4. Rockwood K., Abeysundera M.J., Mitnitski A. How should we grade frailty in nursing home patients?. J Am Med Dir Assoc 2007, 8:595-603.
5. Morley J.E., Perry H.M., Miller D.K. Editorial: Something about frailty. J Gerontol A Biol Sci Med Sci 2002, 57:M698-M704.
6. Gobbens R.J., van Assen M.A., Luijkx K.G., et al. Determinants of frailty. J Am Med Dir Assoc 2010, 11:356-364.
7. Gobbens R.J., van Assen M.A., Luijkx K.G., et al. The Tilburg Frailty Indicator: Psychometric properties. J Am Med Dir Assoc 2010, 11:344-355.
8. van Kan G.A., Rolland Y.M., Morley J.E., et al. Frailty: Toward a clinical definition. J Am Med Dir Assoc 2008, 9:71-72.
9. Gobbens R.J., Luijkx K.G., Wijnen-Sponselee M.T., Schols J.M. In search of an integral conceptual definition of frailty: Opinions of experts. J Am Med Dir Assoc 2010, 11:338-343.
10. van Kan G.A., Rolland Y., Bergman H., et al. The IANA task force on frailty assessment of older people in clinical practice. J Nutr Hlth Aging 2008, 12:29-37.
11. Young Y., Frick K.D., Phelan E.A. Can successful aging and chronic illness coexist in the same individual? A multidimensional concept of successful aging. J Am Med Dir Assoc 2009, 10:87-92.
12. Morley J.E. Successful aging or aging successfully. J Am Med Dir Assoc 2009, 10:85-86.
13. Morley J.E. Caring for the vulnerable elderly: Are available quality indicators appropriate?. J Am Med Dir Assoc 2008, 9:1-3.
14. Morley J.E. Phronesis and the medical director. J Am Med Dir Assoc 2009, 10:149-152.
15. Rolland Y., Abellan van Kan G., Vellas B. Physical activity and Alzheimer's disease: From prevention to therapeutic perspectives. J Am Med Dir Assoc 2008, 9:390-405.
16. Morley J.E. The magic of exercise. J Am Med Dir Assoc 2008, 9:375-377.
17. Colberg S.R., Somma C.T., Sechrist S.R. Physical activity participation may offset some of the negative impact of diabetes on cognitive function. J Am Med Dir Assoc 2008, 9:434-438.
18. Colberg S.R., Zarrabi L., Bennington L., et al. Postprandial walking is better for lowering the glycemic effect of dinner than pre-dinner exercise in type 2 diabetic individuals. J Am Med Dir Assoc 2009, 10:394-397.
19. Landi F., Russo A., Liperoti R., et al. Anorexia, physical function, and incident disability among the frail elderly population: Results from the ilSIRENTE study. J Am Med Dir Assoc 2010, 11:268-274.
20. Gaddipati V.C., Kuriacose R., Copeland R., et al. Vitamin D deficiency: An increasing concern in peripheral arterial disease. J Am Med Dir Assoc 2010, 11:308-311.
21. Gau J.T. Prevalence of vitamin D deficiency/insufficiency practice patterns in nursing homes. J Am Med Dir Assoc 2010, 11:296.
22. Peiris A.N., Bailey B., Manning T., et al. Testing for vitamin D deficiency in veterans-is there a seasonal bias?. J Am Med Dir Assoc 2010, 11:128-131.
23. Morley J.E. Hip fractures. J Am Med Dir Assoc 2010, 11:81-83.
24. Braddy K.K., Imam S.N., Palla K.R., Lee T.A. Vitamin D deficiency/insufficiency practice patterns in a Veterans Health Administration long-term care population: A retrospective analysis. J Am Med Dir Assoc 2009, 10:653-657.
25. Morley J.E. Vitamin D redux. J Am Med Dir Assoc 2009, 10:591-592.
26. Morley J.E. Should all long-term care residents receive vitamin D?. J Am Med Dir Assoc 2007, 8:69-70.
27. Morley J.E. Anorexia, weight loss, and frailty. J Am Med Dir Assoc 2010, 11:225-228.
28. Argilés J.M., Anker S.D., Evans W.J., et al. Consensus on cachexia definitions. J Am Med Dir Assoc 2010, 11:229-230.
29. Landi F., Laviano A., Cruz-Jentoft A.J. The anorexia of aging: Is it a geriatric syndrome?. J Am Med Dir Assoc 2010, 11:153-156.
30. Thomas D.R. But is it malnutrition?. J Am Med Dir Assoc 2009, 10:295-297.
31. Nijs K., de Graaf C., van Staveren W.A., de Groot L.C. Malnutrition and mealtime ambiance in nursing homes. J Am Med Dir Assoc 2009, 10:226-229.
32. Morley J.E., Thomas D.R. Cachexia: New advances in the management of wasting diseases. J Am Med Dir Assoc 2008, 9:219-236.
33. Evans W.J., Morley J.E., Argiles J., et al. Cachexia: A new definition. Clin Nutr 2008, 27:793-799.
34. Yeh S.S., Blackwood K., Schuster M.W. The cytokine basis of cachexia and its treatment: Are they ready for prime time?. J Am Med Dir Assoc 2008, 9:219-236.
35. Morley J.E. Weight loss in the nursing home. J Am Med Dir Assoc 2007, 8:201-204.
36. Kalantar-Zadeh K., Horwich T.B., Oreopoulos A., et al. Risk factor paradox in wasting diseases. Current opinion in clinical nutrition and metabolic care 2007, 10:433-442.
37. Vellas B., Villars H., Abellani G., et al. Overview of the MNA (R)-Its history and challenges. J Nutr 2006, 10:456-463.
38. Wilson M.M., Vaswani S., Liu D., et al. Prevalence and causes of undernutrition in medical outpatients. Am J Med 1998, 104:56-63.
39. Cabrera M.A., Mesas A.E., Garcia A.R., de Andrade S.M. Malnutrition and depression among community-dwelling elderly people. J Am Med Dir Assoc 2007, 8:582-584.
40. Morley J.E. Depression in nursing home residents. J Am Med Dir Assoc 2010, 11:301-303.
41. Thakur M., Blazer D.G. Depression in long-term care. J Am Med Dir Assoc 2008, 9:82-87.
42. Damián J., Pastor-Barriuso R., Valderrama-Gama E. Descriptive epidemiology of undetected depression in institutionalized older people. J Am Med Dir Assoc 2010, 11:312-319.
43. Bischoff-Ferrari H.A. Validated treatments and the therapeutic perspectives regarding nutritherapy. J Nutr Health Aging 2009, 13:737-741.
44. Morley J.E. Sarcopenia: Diagnosis and treatment. J Nutr Health Aging 2008, 12:452-456.
45. Morais J.A., Chevalier S., Gougeon R. Protein turnover and requirements in the healthy and frail elderly. J Nutr Health Aging 2006, 10:272-283.
46. Paddon-Jones D., Rasmussen B.B. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care 2009, 12:86-90.
47. Bourdel-Marchasson I. How to improve nutritional support in geriatric institutions. J Am Med Dir Assoc 2010, 11:13-20.
48. Wilson M.M., Purushothaman R., Morley J.E. Effect of liquid dietary supplements on energy intake in the elderly. Am J Clin Nutr 2002, 75:944-947.
49. van Wetering C.R., Hoogendoorn M., Broekhuizen R., et al. Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: A prespecified subgroup analysis of the INTERCOM trial. J Am Med Dir Assoc 2010, 11:179-187.
50. Dharmarajan T.S. Falls and fractures linked to anemia, delirium, osteomalacia, medications, and more: The path to success is strewn with obstacles!. J Am Med Dir Assoc 2007, 8:549-550.
51. Tamhane U., Voytas J., Aboufakher R., Maddens M. Do hemoglobin and creatinine clearance affect hospital readmission rates from a skilled nursing facility heart failure rehabilitation unit?. J Am Med Dir Assoc 2008, 9:194-198.
52. Dharmarajan T.S., Pankratov A., Morris E., et al. Anemia: Its impact on hospitalizations and length of hospital stay in nursing home and community older adults. J Am Med Dir Assoc 2008, 9:354-359.
53. Argento V., Roylance J., Skudlarska B., et al. Anemia prevalence in a home visit geriatric population. J Am Med Dir Assoc 2008, 9:422-426.
54. Dharmarajan T.S., Banik P., Kanagala M., et al. High prevalence of chronic kidney disease, anemia, and falls in an urban long-term care facility: Relationship or coincidence?. J Am Med Dir Assoc 2010, 11:297-299.
55. Morley J.E. Polypharmacy in the nursing home. J Am Med Dir Assoc 2009, 10:289-291.
56. Fitzgerald S.P., Bean N.G. An analysis of the interactions between individual comorbidities and their treatments-implications for guidelines and polypharmacy. J Am Med Dir Assoc 2010, 11:475-484.
57. Morley J.E. Androgens and aging. Maturitas 2001, 38:61-71.
58. Morley J.E., Perry H.M. Androgen treatment of male hypogonadism in older males. J Steroid Biochem Mol Biol 2003, 85:367-373.
59. Bauer J.M., Kaiser M.J., Sieber C.C. Sarcopenia in nursing home residents. J Am Med Dir Assoc 2008, 9:545-551.
60. Morley J.E. The politics of testosterone. J Sex Med 2007, 4:554-557.
61. Saha B., Rajadhyaksha G.C., Ray S.K. Beneficial effects of nandrolone decanoate in wasting associated with HIV. J Indian Med Assoc 2009, 107:295-299.
62. Sharma S., Arneja A., McLean L., et al. Anabolic steroids in COPD: A review and preliminary results of a randomized trial. Chron Respir Dis 2008, 5:169-176.
63. Tengstrand B., Cederholm T., Soderqvist A., Tidermark J. Effects of protein-rich supplementation and nandrolone on bone tissue after a hip fracture. Clin Nutr 2007, 26:460-465.
64. Frisoli A., Chaves P.H., Pinheiro M.M., Szejnfeld V.L. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: A double-blind, randomized, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci 2005, 60:648-653.
65. Williams J.S., Stein J.H., Ferris T.F. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study. Arch Intern Med 1974, 134:289-292.
66. von Mühlen D., Laughlin G.A., Kritz-Silverstein D., et al. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: The DAWN trial. Osteoporos Int 2008, 19:699-707.
67. Boxer R.S., Kleppinger A., Brindisi J., et al. Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics. Age Ageing 2010, 39:451-458.
68. Muller M., van den Beld A.W., van der Schouw Y.T., et al. Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men. J Clin Endocrinol Metab 2006, 91:3988-3991.
69. Baulieu E.E., Thomas G., Legrain S., et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci U S A 2000, 97:4279-4284.
70. Morley J.E., Kaiser F.E., Perry H.M., et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997, 46:410-413.
71. Wang C., Nieschlag E., Swerdloff R., et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. Eur J Endocrinol 2008, 159:507-514.
72. Morley J.E., Melmed S. Gonadal dysfunction in systemic disorders. Metabolism 1979, 28:1051-1073.
73. Malkin C.J., Pugh P.J., West J.N., et al. Testosterone therapy in men with moderate severity heart failure: A double-blind randomized placebo controlled trial. Eur Heart J 2006, 27:57-64.
74. Caminiti G., Volterrani M., Iellamo F., et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure. A double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009, 54:919-927.
75. Srinivas-Shankar U., Roberts S.A., Connolly M.J., et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: A randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010, 95:639-650.
76. Kenny A.M., Kleppinger A., Gruman C.A., et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Geron A Biol Sci Med Sci 2001, 56:M266-M272.
77. Basaria S., Coviello A.D., Travison T.G., et al. Adverse events associated with testosterone administration. N Engl J Med 2010, 363:109.
78. Calof O.M., Singh A.B., Lee M.L., et al. Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 2005, 60A:1451-1457.
79. Morley J.E. Weight loss in older persons: New therapeutic approaches. Curr Pharma Design 2007, 35:3637-3647.
80. Chapman I.M., Visvanathan R., Hammond A.J., et al. Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women. Am J Clin Nutr 2009, 89:880-889.
81. Lapcevic W.A., French D.D., Campbell R.R. All-cause mortality rates of hip fractures treated in the VHA: Do they differ from Medicare facilities?. J Am Med Dir Assoc 2010, 11:116-119.
82. Quigley P., Bulat T., Kurtzman E., et al. Fall prevention and injury protection for nursing home residents. J Am Med Dir Assoc 2010, 11:284-293.
83. Baumgartner R.N., Waters D.L., Gallagher D., et al. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999, 107:123-136.
84. Morley J.E., Perry H.M., Kaiser F.E., et al. Effects of testosterone replacement therapy in old hypogonadal males: A preliminary study. J Am Geriatr Soc 1993, 41:149-152.
85. Sih R., Morley J.E., Kaiser F.E., et al. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab 1997, 82:1661-1667.
86. Sattler F.R., Castaneda-Sceppa C., Binder E.F., et al. Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab 2009, 94:1991-2001.
87. Storer T.W., Woodhouse L., Magliano L., et al. Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc 2008, 56:1991-1999.
88. Sinha-Hikim I., Comford M., Gaytan H., et al. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab 2006, 91:3024-3033.
89. Page S.T., Amory J.K., Bowman F.D., et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005, 90:1502-1510.
90. Hyde Z., Flicker L., Almeida O.P., et al. Low free testosterone predicts frailty in older men: The Health in Men Study. J Clin Endocrinol Metab 2010, 95:3165-3172.
91. Cawthon P.M., Ensrud K.E., Laughlin G.A., et al. Sex hormones and frailty in older men: The osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab 2009, 94:3806-3815.
92. Travison T.G., Chackelton R., Araujo A.B., et al. Frailty, serum androgens, and the CAG repeat polymorphism: Results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2010, 95:2746-2754.
93. Krasnoff J.B., Basaria S., Pencina M.J., et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: The Framingham Offspring Study. J Clin Endocrinol Metab 2010, 95:2790-2799.
94. Matsumoto A.M. Andropause: Clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002, 57:M76-M99.
95. Amory J.K., Watts N.B., Easley K.A., et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 2004, 89:503-510.
96. Lunenfeld B., Nieschlag E. Testosterone therapy in the aging male. Aging Male 2007, 10:139-153.
97. Chu L.W., Tam S., Lee P.W., et al. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men. Clin Endocrinol (Oxf) 2008, 68:589-598.
98. Pan Y., Zhang H., Acharya A.B., et al. Effect of testosterone on functional recovery in a castrate male rate stroke model. Brain Research 2005, 1043:195-204.
99. Lester P., Haq M., Vadnerkar A., Feuerman M. Falls in the nursing home setting: Does time matter?. J Am Med Dir Assoc 2008, 9:684-686.
100. Morley J.E. Hot topics in geriatrics. J Am Med Dir Assoc 2008, 9:613-616.
101. Cruz-Oliver D.M., Morley J.E. Early detection of cognitive impairment: Do screening tests help?. J Am Med Dir Assoc 2010, 11:1-6.
102. Flood JF, Farr SA, Kaiser FE, et al. Age-related decrease of plasma testosterone in SAMP8 mice-Replacement improves age-related impairment of learning and memory. Physiol Behav 2995;57:669-673.
103. Morley J.E., Kumar V.B., Bernardo A.E., et al. beta-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 2000, 21:1761-1767.
104. Morley J.E. Impotence. Am J Med 1986, 80:897-905.